Search

everythinglearnresearchcommunity

for

Search:↓

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Neurokinin B levels are higher in the placentas of women with PCOS who have female babies.

Insulin resistance is strongly linked to higher androgen levels in women with PCOS.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Women with acne often have higher levels of male hormones and are more likely to be overweight, both of which can make acne worse.

Myo-inositol with magnesium effectively reduces acne and hirsutism in PCOS patients without side effects.

Lowering certain hormone levels improves treatment for hair loss in young men.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Low prolactin in young women may increase heart and metabolism risks.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.

Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.

Hormonal imbalances, especially high androgen levels and insulin resistance, are linked to worse acne in adult women.

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Androgen levels do not determine the type of PCOS symptoms in young females.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Hidradenitis suppurativa improves with antiandrogen therapy.